[en] The aim of the study was to explore the cause of the difference in the maximal rectal dose between the first and second high dose rate (HDR) brachytherapy applications by comparing the thickness of the anterior rectal wall. The rectal dose and the thickness of the anterior rectal wall were analyzed in 26 patients with prostate cancer. After undergoing external beam radiation treatment with a total isocenter dose of 50 Gy, they were treated with HDR brachytherapy of 7.5 Gy/fraction, two fractions daily. The interval between the first HDR brachytherapy session and the second was 5 h. The rectal doses were directly surveyed during irradiation of the HDR brachytherapy. Thickening of the anterior rectal wall was measured at the same level by axial computed tomography scans obtained before the first and second HDR brachytherapy applications. The maximal surveyed rectal doses during the first and second HDR brachytherapy applications were 188±51 cGy and 220±35 cGy, respectively (P<0.01). The fluctuation ratio exceeded 1 in each case. The thickness of the anterior rectal wall before the first and second HDR brachytherapy applications was 18.78±4.34 mm and 14.95±4.09 mm (P<0.01), respectively. The fluctuation difference exceeded 0 in each case. The different rectal dose is attributable to thinning of the anterior rectal wall. The total rectal dose is within the range of doses at risk of exerting a toxic effect on the rectum. (author)

[en] The purpose of this study was to evaluate the effectiveness and safety of the combination of external irradiation and interstitial brachytherapy twice per day for prostate cancer. The cases were 42 patients with prostate cancer (4 cases in Stage A, 14 in Stage B, 20 in Stage C and 4 in Stage D) who underwent external irradiation of 50 Gy to the prostate gland including 30 Gy to the pelvis and interstitial brachytherapy of 5.5 Gy x 2/day in 4 cases, 7.0 Gy x 2/day in 2 cases and 7.5 Gy x 2/day in 36 cases. The average age was 77.5 (range 61 to 89) years old. Prostate specific antigen (PSA) values after the combinated radiation therapy dropped in each case. Three cases with PSA failure were noted during the average observation term of 12 months. No cases with stage A, B or less than Gleason score 6 were associated with PSA failure. Biochemically no evidence of disease (bNED) survival curve showed significant PSA failure in the cases with PSA values of ≥30 ng/ml than in those with PSA values of <30 ng/ml. Transient rectal bleeding (2.3%), diarrhea (7%) and perianal pain (4.7%) as adverse effects of radiation treatment were noted. Initial results of external irradiation and interstitial brachytherapy twice a day are promising especially for aged cases with early prostate cancer. However, longer-term observation is needed to evaluate the real effectiveness and the adverse effect of this combinated radiation therapy. (author)

[en] Purpose. We evaluated the suitability of Dacron, polytetrafluoroethylene (PTFE), and small intestinal submucosa (SIS) as a covering material for stent-grafts placed in the portal vein as compared with a bare stent. Methods. Using 24 beagle dogs, either bare stents or stent-grafts covered with Dacron, PTFE, or SIS were placed in the main trunk of the portal vein in 6 animals each. Portography was performed immediately after stent placement, and at 2, 4, and 12 weeks thereafter. Next, the extracted stents or stent-grafts were examined histopathologically. Neointimal thickness adjacent to the stent wire and at the midportion between the stent wires was compared among the groups. Then, the neointimal thickness at the sub- and supragraft sites was compared between each stent-graft group. Serial changes in the histologic features of the thickened neointima were also investigated. Results. No significant difference was noted in the mean stenotic ratio of the portal vein diameter between the bare stent and PTFE groups, whereas it was significantly higher in the Dacron and SIS groups compared with the bare stent group. In neither of the studies on neointimal thickness adjacent to the stent wire and at the midportion between the stent wires were any significant differences noted between the neointimal thickness of the bare stent group and the sum of the neointimal thickness of the PTFE group, whereas the sum of the neointimal thickness of the Dacron and SIS groups was significantly greater than that of the bare stent group at both sites. In the comparison of the supragraft neointimal thickness, the SIS group showed significantly greater thickness than the PTFE group, while the difference between the Dacron and PTFE groups was not significant. In the comparison of the subgraft neointimal thickness, the Dacron and SIS groups showed significantly greater thickness than the PTFE group. Conclusion. The present results indicate that of the three covering materials examined here, PTFE is the most suitable material for grafts placed in the portal vein